First Command Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.68K Hold
54
﹤0.01% 764
2025
Q4
$4.58K Hold
54
﹤0.01% 539
2025
Q3
$3.92K Hold
54
﹤0.01% 486
2025
Q2
$3.54K Hold
54
﹤0.01% 451
2025
Q1
$3.81K Buy
+54
New +$3.75K ﹤0.01% 420

Other funds holding IHE

First Command Advisory Services's IHE Position: Q1 2026 in Review

First Command Advisory Services held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 54 shares worth $4.68K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

First Command Advisory Services first reported a position in IHE in Q1 2025 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • First Command Advisory Services held 54 shares of iShares US Pharmaceuticals ETF worth $4.68K as of Q1 2026.
  • First Command Advisory Services left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of First Command Advisory Services's portfolio in Q1 2026, its #764 holding.
  • First Command Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q1 2025 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on First Command Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.